Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration
|更新时间:2025-01-16
|
Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration
“The latest research found that Huoluo Xiaoling Pill can significantly inhibit triple negative breast cancer, regulate immune cell subsets and enhance anti-tumor immunity by enhancing TCF1+CD8+stem cell like T cell tumor invasion and CD8+T cell activity.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 4, Pages: 108-115(2025)
LUO bo,ZHANG Qu,SUN Yujie,et al.Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(04):108-115.
LUO bo,ZHANG Qu,SUN Yujie,et al.Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(04):108-115. DOI: 10.13422/j.cnki.syfjx.20242021.
Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration